BlueRock Therapeutics Compagnie réclamée
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.
Lire la suite
Great excited journey so far, look forward to many years to come, and our success is the success for a lot of patients and family.
Quelles sont les meilleures choses à propos de votre équipe?
Friendly and supportive, purpose driven for common good
Quelle est la meilleure partie de votre programme de rémunération?
401K contribution match and HSA
Qu’est-ce qui est le plus positif à propos de la culture et de l’environnement de votre entreprise?
Caring, friendly, supportive and trust
Qu’est-ce qui vous plaît le plus dans l’équipe de direction?
Great transparency with clear mission and roadmap for the teams
Qu’est-ce qui vous rend le plus heureux au travail?
Learning, sense of urgency, and passion for the good cause.
Other Employee Reviews for BlueRock Therapeutics
×